Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 10/2006

01.10.2006 | Case Report

Choroidal vein and artery occlusion following photodynamic therapy in eyes with pathologic myopia

verfasst von: Kyoko Ohno-Matsui, Muka Moriyama, Kengo Hayashi, Manabu Mochizuki

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 10/2006

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To describe highly myopic patients in which either the large choroidal veins or arteries were occluded following PDT treatment.

Methods

Demographic features of two highly myopic patients in which large choroidal vessels were occluded at 1 week following PDT, among a total of 23 patients who received PDT due to choroidal neovascularization (CNV) caused by high myopia, were demonstrated.

Results

In case 1, ICG angiography demonstrated the complete occlusion of several large choroidal veins within the laser-applied area at 1 week after PDT. In case 2, ICG angiography demonstrated an occlusion of choroidal artery emanating from beneath the CNV. One month after PDT, re-perfusion of the occluded choroidal vessels was noted in both patients.

Conclusion

Occlusion of choroidal veins has never been reported in eyes with CNV treated by verteporfin therapy. Although further studies are necessary, occlusion of large choroidal vessels might happen in highly myopic eyes more commonly than expected. ICG angiography at 1 week after PDT was useful to evaluate the impact of PDT on large choroidal vessels.
Literatur
1.
Zurück zum Zitat Coscas F, Stanescu D, Souied E, Coscas G, Soubrane G (2004) SLO ICG analysis of choroidal changes after multiple (more than three) re-treatment sessions with PDT verteporfin of CNV in AMD. ARVO abstract (#3165) Coscas F, Stanescu D, Souied E, Coscas G, Soubrane G (2004) SLO ICG analysis of choroidal changes after multiple (more than three) re-treatment sessions with PDT verteporfin of CNV in AMD. ARVO abstract (#3165)
2.
Zurück zum Zitat Klais CM, Ober MD, Freund KB, Ginsburg LH, Luckie A, Mauget-Faysse M, Coscas G, Gross NE, Yannuzzi LA (2005) Choroidal infarction following photodynamic therapy with verteporfin. Arch Ophthalmol 123:1149–1153CrossRefPubMed Klais CM, Ober MD, Freund KB, Ginsburg LH, Luckie A, Mauget-Faysse M, Coscas G, Gross NE, Yannuzzi LA (2005) Choroidal infarction following photodynamic therapy with verteporfin. Arch Ophthalmol 123:1149–1153CrossRefPubMed
3.
Zurück zum Zitat Lai TYY, Chan WM, Lam DSC (2004) Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy. Am J Ophthalmol 137:826–833CrossRefPubMed Lai TYY, Chan WM, Lam DSC (2004) Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy. Am J Ophthalmol 137:826–833CrossRefPubMed
4.
Zurück zum Zitat Lam DSC, Chan WM, Liu DTL, Fan DSP, Lai WW, Chong KKL (2004) Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up. Br J Ophthalmol 88:1315–1319CrossRefPubMed Lam DSC, Chan WM, Liu DTL, Fan DSP, Lai WW, Chong KKL (2004) Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up. Br J Ophthalmol 88:1315–1319CrossRefPubMed
5.
Zurück zum Zitat Quaranta M, Arnold J, Coscas G, Francais C, Quentel G, Kuhn D, Soubrane G (1996) Indocyanine green angiographic features of pathologic myopia. Am J Ophthalmol 122:663–671PubMed Quaranta M, Arnold J, Coscas G, Francais C, Quentel G, Kuhn D, Soubrane G (1996) Indocyanine green angiographic features of pathologic myopia. Am J Ophthalmol 122:663–671PubMed
6.
Zurück zum Zitat Schlotzer-Schrehardt U, Viestenz A, Naumann GOH, Laqua H, Michels S, Schmidt-Erfurth U (2002) Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefe’s Arch Clin Exp Ophthalmol 240:748–757PubMedCrossRef Schlotzer-Schrehardt U, Viestenz A, Naumann GOH, Laqua H, Michels S, Schmidt-Erfurth U (2002) Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefe’s Arch Clin Exp Ophthalmol 240:748–757PubMedCrossRef
7.
Zurück zum Zitat Schmidt-Erfurth U, Niemeyer M, Geitzenauer W, Michels S (2005) Time course and morphology of vascular effects associated with photodynamic therapy. Ophthalmology 112:2061–2069CrossRefPubMed Schmidt-Erfurth U, Niemeyer M, Geitzenauer W, Michels S (2005) Time course and morphology of vascular effects associated with photodynamic therapy. Ophthalmology 112:2061–2069CrossRefPubMed
8.
Zurück zum Zitat Stur M, Ansari-Shahrezaei S (2001) The effect of axial length on laser spot size and laser irradiance. Arch Ophthalmol 119:1323–1328PubMed Stur M, Ansari-Shahrezaei S (2001) The effect of axial length on laser spot size and laser irradiance. Arch Ophthalmol 119:1323–1328PubMed
9.
Zurück zum Zitat Verteporfin in Photodynamic Therapy (VIP) Study Group (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia. 2-year results of a randomized clinical trial-VIP report no. 3. Ophthalmology 110:667–673CrossRef Verteporfin in Photodynamic Therapy (VIP) Study Group (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia. 2-year results of a randomized clinical trial-VIP report no. 3. Ophthalmology 110:667–673CrossRef
Metadaten
Titel
Choroidal vein and artery occlusion following photodynamic therapy in eyes with pathologic myopia
verfasst von
Kyoko Ohno-Matsui
Muka Moriyama
Kengo Hayashi
Manabu Mochizuki
Publikationsdatum
01.10.2006
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 10/2006
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-006-0303-9

Weitere Artikel der Ausgabe 10/2006

Graefe's Archive for Clinical and Experimental Ophthalmology 10/2006 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.